Your browser doesn't support javascript.
The SARS-CoV-2 as an instrumental trigger of autoimmunity.
Dotan, Arad; Muller, Sylviane; Kanduc, Darja; David, Paula; Halpert, Gilad; Shoenfeld, Yehuda.
  • Dotan A; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel. Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Muller S; CNRS-Strasbourg University Unit Biotechnology and cell signaling/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France; Federation Hospital-University (FHU) OMICARE, Federation of Translational Medicine of Strasbourg (FMTS), Strasbourg University, Strasbourg, France; Universi
  • Kanduc D; Department of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, Italy.
  • David P; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel. Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Halpert G; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel. Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg 199034, Russian Fed
  • Shoenfeld Y; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel. Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg 199034, Russian Fed
Autoimmun Rev ; 20(4): 102792, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1086776
Semantic information from SemMedBD (by NLM)
1. 2019 novel coronavirus CAUSES Autoimmune Diseases
Subject
2019 novel coronavirus
Predicate
CAUSES
Object
Autoimmune Diseases
2. COVID-19 PROCESS_OF Patients
Subject
COVID-19
Predicate
PROCESS_OF
Object
Patients
3. Symptoms PROCESS_OF Patients
Subject
Symptoms
Predicate
PROCESS_OF
Object
Patients
4. Autoimmune Diseases COEXISTS_WITH Disease
Subject
Autoimmune Diseases
Predicate
COEXISTS_WITH
Object
Disease
5. Neutrophil Extracellular Traps LOCATION_OF 2019 novel coronavirus
Subject
Neutrophil Extracellular Traps
Predicate
LOCATION_OF
Object
2019 novel coronavirus
6. Vaccination AFFECTS Autoimmune Diseases
Subject
Vaccination
Predicate
AFFECTS
Object
Autoimmune Diseases
7. 2019 novel coronavirus CAUSES Autoimmune Diseases
Subject
2019 novel coronavirus
Predicate
CAUSES
Object
Autoimmune Diseases
8. COVID-19 PROCESS_OF Patients
Subject
COVID-19
Predicate
PROCESS_OF
Object
Patients
9. Symptoms PROCESS_OF Patients
Subject
Symptoms
Predicate
PROCESS_OF
Object
Patients
10. Autoimmune Diseases COEXISTS_WITH Disease
Subject
Autoimmune Diseases
Predicate
COEXISTS_WITH
Object
Disease
11. Neutrophil Extracellular Traps LOCATION_OF 2019 novel coronavirus
Subject
Neutrophil Extracellular Traps
Predicate
LOCATION_OF
Object
2019 novel coronavirus
12. Vaccination AFFECTS Autoimmune Diseases
Subject
Vaccination
Predicate
AFFECTS
Object
Autoimmune Diseases
ABSTRACT
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state of the immune system. It had been established long ago that viruses are a substantial component of environmental factors that contribute to the production of autoimmune antibodies, as well as autoimmune diseases. Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) are viruses that withhold these autoimmune abilities. In a similar manner, SARS-CoV-2 may be counted to similar manifestations, as numerous records demonstrating the likelihood of COVID-19 patients to develop multiple types of autoantibodies and autoimmune diseases. In this review, we focused on the association between COVID-19 and the immune system concerning the tendency of patients to develop over 15 separate types of autoantibodies and above 10 distinct autoimmune diseases. An additional autoimmunity manifestation may be one of the common initial symptoms in COVID-19 patients, anosmia, the complete loss of the ability to sense smell, and other olfactory alterations. We summarize current knowledge on principal mechanisms that may contribute to the development of autoimmunity in the disease the ability of SARS-CoV-2 to hyper-stimulate the immune system, induce excessive neutrophil extracellular traps formation with neutrophil-associated cytokine responses and the molecular resemblance between self-components of the host and the virus. Additionally, we will examine COVID-19 potential risk on the new-onsets of autoimmune diseases, such as antiphospholipid syndrome, Guillain-Barré syndrome, Kawasaki disease and numerous others. It is of great importance to recognize those autoimmune manifestations of COVID-19 in order to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period. Lastly, an effective vaccine against SARS-CoV-2 may be the best solution in dealing with the ongoing pandemic. We will discuss the new messenger RNA vaccination strategy with an emphasis on autoimmunity implications.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Epstein-Barr Virus Infections / COVID-19 Limits: Humans Language: English Journal: Autoimmun Rev Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.autrev.2021.102792

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Epstein-Barr Virus Infections / COVID-19 Limits: Humans Language: English Journal: Autoimmun Rev Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.autrev.2021.102792